Hong Kong Telecom Services and Carriers Stock News

CTF Services has recently applied to issue debt instruments worth up to RMB5 billion, signalling a move to raise substantial capital through borrowing. This sizeable funding initiative could reshape the company’s capital structure and financial flexibility, with potential implications for its multi-segment operations. Next, we’ll examine how CTF Services’ planned RMB5 billion debt raise may influence its existing investment narrative and risk profile. Find companies with promising cash flow...

On 12 January 2026, AbbVie and RemeGen announced an exclusive licensing agreement for RC148, a PD-1/VEGF-targeted bispecific antibody, giving AbbVie rights outside Greater China in exchange for a US$650 million upfront payment plus very large potential milestone payments and tiered, double-digit royalties. This deal not only validates RemeGen’s immuno-oncology platform, but also ties its future RC148 opportunity to AbbVie’s global ADC and solid tumor portfolio. We’ll now examine how this...

Guangdong Investment (SEHK:270) has come into focus following the sudden resignation of Ms. Bai Tao as Executive Director, Chairman of the Board and Chairman of the Nomination Committee, effective 6 January 2026. See our latest analysis for Guangdong Investment. The leadership change comes after a mixed period for investors, with a 1 month share price return of 1.77% and a 1 year total shareholder return of 23.17%. However, the 5 year total shareholder return shows a 29% decline, suggesting...

Marvel Games and NetEase Games recently launched Season 6: Night at the Museum for Marvel Rivals, adding Deadpool as a new triple-role hero alongside fresh maps, accessories, and quality-of-life updates. This content update highlights how NetEase is using high-profile collaborations and frequent in-game refreshes to support engagement and monetization in its global gaming portfolio. We’ll now examine how the Deadpool-led Season 6 update for Marvel Rivals could influence NetEase’s existing...

Earlier in January 2026, JP Morgan upgraded Jiangxi Copper to Neutral, citing a more constructive view on copper amid supply disruptions, ongoing industry mergers and acquisitions, and a milder-than-expected application of China’s “anti-involution” policy. This shift highlights how policy implementation and tightening supply conditions can reshape sentiment toward China’s basic materials sector, with Jiangxi Copper positioned at the heart of these themes. We’ll now examine how JP Morgan’s...

Qingdao Port International recently amended its Articles of Association to give its unit Qingdao Port Logistics effective control over Ganglianhai Logistics, allowing the formerly jointly controlled entity to be consolidated as a subsidiary despite each partner still holding 50% equity. This shift in control structure, classified as a connected transaction under Hong Kong Listing Rules without requiring independent shareholder approval, materially reshapes how Ganglianhai’s operations and...

Ascletis Pharma Inc. reported that it has received U.S. FDA IND clearance for a 13‑week Phase II trial of its oral small‑molecule GLP‑1 candidate ASC30 in type 2 diabetes, following dosing plans up to 80 mg and focusing on HbA1c, fasting glucose, weight, and safety outcomes. The company also released Phase II obesity data showing dose‑dependent weight loss and relatively low discontinuation and vomiting rates, underlining ASC30’s potential as an in‑house oral GLP‑1 receptor agonist targeting...

Public Financial Holdings (SEHK:626) has reported a very different set of numbers for FY 2025, with first half revenue of HK$529.2 million and basic EPS of HK$0.002338, compared with total revenue of HK$429.6 million and basic EPS of HK$0.031416 in the first half of FY 2024. Over the trailing twelve months, revenue has ranged from HK$737.5 million to HK$1,154.2 million, while basic EPS has moved from a loss of HK$0.910256 to a profit of HK$0.073. This sets up a story where the key question is...

Earlier this week, Volvo Cars, majority-owned by Geely Automobile Holdings, paused work at its Gothenburg battery plant under construction, laying off 75 employees after failing to secure a new partner following Northvolt’s bankruptcy. The move highlights uncertainty around Volvo’s in-house EV battery production roadmap, which could have knock-on effects for Geely’s broader electric vehicle supply chain plans. We’ll now examine how this pause in Volvo’s Gothenburg battery project could...

China Hanking Holdings (SEHK:3788) moved into focus after subsidiary Hanking Gold Limited reported updated studies for its Australian projects, with combined Ore Reserve now 2.62 Moz and JORC gold resource assessed at 5.54 Moz. See our latest analysis for China Hanking Holdings. The updated Ore Reserve figures arrive after an intense run in the shares, with a 1-year total shareholder return that is very large and a year to date share price return of 20.86% despite a 5.44% one day decline and...

Luk Fook Holdings (International) (SEHK:590) released its third quarter sales update, highlighting double digit gains in overall retail sales value, retailing revenue, and same store sales across Hong Kong, Macao, overseas, and Mainland China. See our latest analysis for Luk Fook Holdings (International). The third quarter sales beat comes at a time when momentum in Luk Fook Holdings (International)'s shares has already been building, with a 12.17% 7 day share price return, an 11.44% 30 day...

As global markets kick off the year with a rally, driven by investors looking beyond geopolitical tensions, small-cap and value shares have outperformed, signaling potential opportunities in overlooked sectors. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.

Why the latest sales and revenue update matters for investors China Resources Land (SEHK:1109) has released unaudited figures for 2025, showing recurring and rental income growth alongside a decline in full year gross contracted sales and contracted gross floor area. See our latest analysis for China Resources Land. The unaudited 2025 update lands after a period where the share price has shown mixed momentum, with a 1 month share price return of 8.64% and a 1 year total shareholder return of...

Hengan International Group recently granted 18.5 million existing shares, worth about HK$510 million, to 962 selected employees and directors under a long‑term incentive plan that will vest through January 2029 with service, conduct and clawback conditions. Because the awards are funded entirely by shares bought on the open market, the plan strengthens alignment between management and shareholders without adding financial assistance from the group itself. Next, we’ll consider how this...

361 Degrees International (SEHK:1361) just reported approximately 10% retail sales growth in both core and kids products for Q4 2025, alongside high double digit e commerce growth compared with the prior year period. See our latest analysis for 361 Degrees International. The latest trading update comes after a strong run for investors, with a year to date share price return of 9.67% and a 1 year total shareholder return of 55.03%. Over 5 years, the total shareholder return is more than 5x,...

MSCI recently upgraded Sino Land Company Limited’s ESG rating from ‘AA’ to the highest ‘AAA’ level, placing it among the top 5% of performers in its industry and recognizing its alignment with international environmental, social and governance standards. This move underscores how Sino Land is embedding ESG considerations into its long-term business strategy, using sustainability initiatives as a lever for value creation and innovation. We’ll now examine how Sino Land’s new MSCI ‘AAA’ ESG...

CGN Mining’s latest production update CGN Mining (SEHK:1164) has released unaudited natural uranium production figures for the fourth quarter and full year 2025, giving investors fresh data on volumes and operational output across its portfolio. See our latest analysis for CGN Mining. The fresh production figures land after a strong period for the stock, with a 24.66% 1 month share price return and a very large 5 year total shareholder return that suggests sustained investor interest rather...

BYD (SEHK:1211) is back in focus after reports that Ford is in talks to source BYD batteries for hybrid vehicles outside the U.S. This highlights how battery supply relationships can shape investor thinking. See our latest analysis for BYD. The Ford talks arrive after a choppy period for BYD's share price, with a 7 day share price return of 4.7% and a 30 day gain of 4.8%. The 90 day share price return shows a 4.0% decline, suggesting momentum has recently picked up from a softer patch, and...

If you are wondering whether Xiaomi's current share price reflects its true worth, you are not alone and this article is designed to help you frame that question clearly. Xiaomi's stock has seen mixed recent returns, with a 0.4% decline over 7 days, a 7.4% decline over 30 days and a 6.0% decline year to date, while still posting a 10.2% return over 1 year, a very large 3 year return and a 22.3% return over 5 years. Recent coverage has focused on how Xiaomi sits within the global smartphone...

As we enter 2026, Asian markets are experiencing a wave of investor optimism, with major indices reaching new highs despite ongoing geopolitical tensions. This backdrop presents an intriguing opportunity for investors exploring the realm of penny stocks—companies that may be small or relatively unknown but hold potential for significant growth. Though the term "penny stock" might sound outdated, these investments can still offer surprising value when backed by strong financial health. In this...

It's not a stretch to say that ETS Group Limited's ( HKG:8031 ) price-to-sales (or "P/S") ratio of 1x right now seems...

Key Insights The projected fair value for Simcere Pharmaceutical Group is HK$22.34 based on 2 Stage Free Cash Flow to...

The latest development at Alphamab Oncology (SEHK:9966) involves China’s regulator formally accepting its new drug application for KN035, in combination with Gemcitabine and Oxaliplatin, for first-line treatment of unresectable or metastatic biliary tract cancer. See our latest analysis for Alphamab Oncology. After the NMPA accepted the KN035 filing, Alphamab Oncology’s HK$10.28 share price sits alongside a 1-year total shareholder return of 216.31%, while the 90-day share price return of a...

Inspur Digital Enterprise Technology Limited ( HKG:596 ), is not the largest company out there, but it saw a...